Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604426041> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2604426041 abstract "Objectives The aim of this study was to report the prevalence of interferon (IFN)-associated retinopathy and other serious ocular complications in a prospectively studied group of children with chronic hepatitis C virus (HCV) receiving pegylated IFN α2b and ribavirin. Patients and methods Prospective comprehensive ophthalmologic examinations were performed by the first author (D.H.A.R.K.) for all included children bilaterally at 0, 12, 24, and 48 weeks after the start of treatment, and at 6 months after the end of treatment. Data recorded included visual complaints, visual acuity, pupillary reactions, and retinal findings. Results All patients aged 3–17 years who were healthy enough to participate in an ophthalmological examination were included. The number of children who remained on treatment and underwent ophthalmologic examinations was 136 after 48 weeks of treatment (90 boys and 46 girls). No patient had ischemic retinopathy at the screening eye examination before initiation of treatment. After 24 weeks of treatment, two (1.5%) patients developed anterior uveitis and another two (1.5%) patients developed retinal ischemia with cotton-wool spots. Conclusion Ophthalmologic complications are infrequent in children who are treated with pegylated IFN α2b for HCV (3%). Because of the potential severity of ischemic retinopathy and uveitis, prospective ocular assessment should remain a part of the monitoring strategy for children who are treated with IFN for HCV." @default.
- W2604426041 created "2017-04-14" @default.
- W2604426041 creator A5038147117 @default.
- W2604426041 creator A5081359181 @default.
- W2604426041 creator A5086051787 @default.
- W2604426041 date "2016-01-01" @default.
- W2604426041 modified "2023-09-27" @default.
- W2604426041 title "Ocular manifestations in Egyptian children with chronic hepatitis C treated with pegylated interferon and ribavirin" @default.
- W2604426041 doi "https://doi.org/10.4103/2090-0686.202259" @default.
- W2604426041 hasPublicationYear "2016" @default.
- W2604426041 type Work @default.
- W2604426041 sameAs 2604426041 @default.
- W2604426041 citedByCount "0" @default.
- W2604426041 crossrefType "journal-article" @default.
- W2604426041 hasAuthorship W2604426041A5038147117 @default.
- W2604426041 hasAuthorship W2604426041A5081359181 @default.
- W2604426041 hasAuthorship W2604426041A5086051787 @default.
- W2604426041 hasBestOaLocation W26044260411 @default.
- W2604426041 hasConcept C118487528 @default.
- W2604426041 hasConcept C126322002 @default.
- W2604426041 hasConcept C134018914 @default.
- W2604426041 hasConcept C141071460 @default.
- W2604426041 hasConcept C187212893 @default.
- W2604426041 hasConcept C188816634 @default.
- W2604426041 hasConcept C203014093 @default.
- W2604426041 hasConcept C2522874641 @default.
- W2604426041 hasConcept C2776015282 @default.
- W2604426041 hasConcept C2776194053 @default.
- W2604426041 hasConcept C2776408679 @default.
- W2604426041 hasConcept C2776455275 @default.
- W2604426041 hasConcept C2776461080 @default.
- W2604426041 hasConcept C2776689232 @default.
- W2604426041 hasConcept C2778257484 @default.
- W2604426041 hasConcept C2778313320 @default.
- W2604426041 hasConcept C2778328719 @default.
- W2604426041 hasConcept C2779134260 @default.
- W2604426041 hasConcept C2780040827 @default.
- W2604426041 hasConcept C555293320 @default.
- W2604426041 hasConcept C71924100 @default.
- W2604426041 hasConceptScore W2604426041C118487528 @default.
- W2604426041 hasConceptScore W2604426041C126322002 @default.
- W2604426041 hasConceptScore W2604426041C134018914 @default.
- W2604426041 hasConceptScore W2604426041C141071460 @default.
- W2604426041 hasConceptScore W2604426041C187212893 @default.
- W2604426041 hasConceptScore W2604426041C188816634 @default.
- W2604426041 hasConceptScore W2604426041C203014093 @default.
- W2604426041 hasConceptScore W2604426041C2522874641 @default.
- W2604426041 hasConceptScore W2604426041C2776015282 @default.
- W2604426041 hasConceptScore W2604426041C2776194053 @default.
- W2604426041 hasConceptScore W2604426041C2776408679 @default.
- W2604426041 hasConceptScore W2604426041C2776455275 @default.
- W2604426041 hasConceptScore W2604426041C2776461080 @default.
- W2604426041 hasConceptScore W2604426041C2776689232 @default.
- W2604426041 hasConceptScore W2604426041C2778257484 @default.
- W2604426041 hasConceptScore W2604426041C2778313320 @default.
- W2604426041 hasConceptScore W2604426041C2778328719 @default.
- W2604426041 hasConceptScore W2604426041C2779134260 @default.
- W2604426041 hasConceptScore W2604426041C2780040827 @default.
- W2604426041 hasConceptScore W2604426041C555293320 @default.
- W2604426041 hasConceptScore W2604426041C71924100 @default.
- W2604426041 hasLocation W26044260411 @default.
- W2604426041 hasOpenAccess W2604426041 @default.
- W2604426041 hasPrimaryLocation W26044260411 @default.
- W2604426041 isParatext "false" @default.
- W2604426041 isRetracted "false" @default.
- W2604426041 magId "2604426041" @default.
- W2604426041 workType "article" @default.